AHN Virtual Forum - “Monoclonal Antibody Therapy in Veterinary Medicine – Allergic and Atopic Dermatitis”
Pathomechanisms involved in the allergic /atopic dermatitis will be discussed. Dr. Bruce Hammerberg will discuss testing chimeric recombinant proteins with specificity for IgE and the high affinity receptor of IgE responsible for inflammatory mediator release from mast cells and basophils. Dr. Andrew Hillier, will illustrate how understanding the mechanism resulted in the approval of the first monoclonal antibody therapy in companion animal medicine. This presentation will outline the research that resulted in the development of lokivetmab, its performance in the field, and how it has helped change the management of allergic and atopic dermatitis in dogs.
Agenda
Bruce Hammerberg, PhD, Professor, Parasitology, College of Veterinary Medicine, NC State University
Dr. Bruce Hammerberg joined the College of Veterinary Medicine at North Carolina State University in1982. Prior to that he was faculty at the College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, Virginia. He has a BS and DVM degrees from Michigan State University. Dr. Hammerberg has practiced as a veterinarian in New Haven, Connecticut and Charlotte, Michigan.
The focus of his research is on development of biological therapies for allergic diseases. Allergic diseases in dogs, cats and horses are important concerns for veterinary medicine; and, the near identical presentation and treatment approach in atopic dermatitis of dogs and humans encourages his efforts to work with canine atopic dermatitis for purposes of both veterinary and human medicine applications.
Andrew Hillier, BVSc, MANZCVS (Canine Medicine), Diplomate American College of Veterinary Dermatology, Director of Dermatology Medical Strategy at Zoetis
Dr. Andy Hillier is from South Africa where he went to veterinary school. He spent 8 years in companion animal practice in South Africa and Australia before going to the University of Florida to complete a residency in dermatology. He was on faculty at Ohio State University for 17 years, becoming a full professor and head of the Dermatology and Otology Service.
Dr. Hillier joined Zoetis as a full-time employee in May 2013 as a senior veterinary specialist. He now serves as the Director of Dermatology Medical Strategy and Field Specialists at Zoetis PETCARE.
For questions or more information, contact:
Hannah Cole
Program Manager, Science and Technology Development
Science and Technology Development
919-549-8840
| hannah_cole@ncbiotech.org
This is a virtual event.